Rohr UP, Binder C, Dieterle T, Giusti F, Messina CG, Toerien E, et al. The value of in vitro diagnostic testing in medical practice: a status report. PLoS One 2016;11:e0149856.CrossrefWeb of ScienceGoogle Scholar
Findeisen P, Zahn I, Fiedler GM, Leichtle AB, Wang S, Soria G, et al. Doubling immunochemistry laboratory testing efficiency with the cobas e 801 module while maintaining consistency in analytical performance. Clin Biochem 2018;58: 86–93.Web of ScienceCrossrefGoogle Scholar
Fruttero ER, Picciolo G, De Matteis JA. Operative performances and efficiency for infectious disease testing of two immunochemistry analyzers – Abbott ARCHITECT i2000SR and DiaSorin Liaison XL. Clin Chem Lab Med 2015;53:e19–23.Web of SciencePubMedGoogle Scholar
Ricós FindeisenC, Alvarez V, Cava F, García-Lario JV, Hernández A, Jiménez CV, et al. Desirable specifications for total error, imprecision, and bias, derived from intra- and inter-individual biologic variation. The 2014 update. Available at: http://www.westgard.com/biodatabase1.htm#1. Accessed: August 2018.
About the article
Published Online: 2019-03-15
Published in Print: 2019-09-25
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: This non-interventional multicenter study was designed and sponsored by Roche Diagnostics GmbH, Mannheim. cobas, cobas E, cobaS C, ELECSYS are trademarks of Roche.
Employment or leadership: S. Engelmann and K. Klopprogge are employees of Roche Diagnostics GmbH.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.